These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14729778)

  • 21. Single-photon emission computed tomography for assessment of myocardial viability.
    Schinkel AF; Valkema R; Geleijnse ML; Sijbrands EJ; Poldermans D
    EuroIntervention; 2010 May; 6 Suppl G():G115-22. PubMed ID: 20542817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gated SPECT myocardial perfusion imaging for the prediction of incident heart failure an old dog learns a new trick.
    Soman P; Udelson JE
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1401-3. PubMed ID: 20083075
    [No Abstract]   [Full Text] [Related]  

  • 23. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
    D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The basis of chronic ischemic reversible left ventricular dysfunction (hibernating myocardium)].
    Mates M; Veselka J
    Cesk Fysiol; 1999 Feb; 48(1):4-8. PubMed ID: 10377599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular regional asynchrony: Earliest marker for ischemic cardiomyopathy?
    Vij A; Malhotra S
    J Nucl Cardiol; 2021 Jun; 28(3):1051-1054. PubMed ID: 32901419
    [No Abstract]   [Full Text] [Related]  

  • 26. Myocardial dysfunction: hibernation and remodelling.
    Köszegi Z; Balogh E
    Lancet; 2003 Oct; 362(9393):1416-7; author reply 1417. PubMed ID: 14585649
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial viability: unresolved issues.
    Iskandrian AS
    J Nucl Med; 1996 May; 37(5):794-7. PubMed ID: 8965147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concept and evaluation of hibernating myocardium.
    Rahimtoola SH
    Annu Rev Med; 1999; 50():75-86. PubMed ID: 10073264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiac decompensation: mechanism of reversibility].
    Melin J; Vanoverschelde JL
    Bull Mem Acad R Med Belg; 1997; 152(1):101-8; discussion 108-11. PubMed ID: 9491624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial stunning and hibernation.
    Rinaldi CA; Hall RJ
    Indian Heart J; 1996; 48(6):721-5. PubMed ID: 9062030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic hibernating myocardium in sheep can occur without degenerating events and is reversed after revascularization.
    Verheyen F; Racz R; Borgers M; Driesen RB; Lenders MH; Flameng WJ
    Cardiovasc Pathol; 2014; 23(3):160-8. PubMed ID: 24529701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention: clinical significance of post-ischemic diastolic stunning.
    Ishii K; Suyama T; Imai M; Maenaka M; Yamanaka A; Makino Y; Seino Y; Shimada K; Yoshikawa J
    J Am Coll Cardiol; 2009 Oct; 54(17):1589-97. PubMed ID: 19833257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link.
    Camici PG; Dutka DP
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H929-36. PubMed ID: 11179032
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of myocardial viability after myocardial infarction.
    Di Carli MF
    J Nucl Cardiol; 2002; 9(2):229-35. PubMed ID: 11986569
    [No Abstract]   [Full Text] [Related]  

  • 36. The perfusable tissue index: a marker of myocardial viability.
    Knaapen P; Boellaard R; Götte MJ; van der Weerdt AP; Visser CA; Lammertsma AA; Visser FC
    J Nucl Cardiol; 2003; 10(6):684-91. PubMed ID: 14668782
    [No Abstract]   [Full Text] [Related]  

  • 37. Predicting benefit from revascularization in patients with ischemic heart failure: imaging of myocardial ischemia and viability.
    Buckley O; Di Carli M
    Circulation; 2011 Feb; 123(4):444-50. PubMed ID: 21282521
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hibernation and stunning: conditions with reversible left ventricular dysfunction].
    Hansen PR
    Ugeskr Laeger; 1997 Sep; 159(37):5537-9. PubMed ID: 9312926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of hibernation to heart failure.
    Camici PG; Rimoldi OE
    Ann Med; 2004; 36(6):440-7. PubMed ID: 15513295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunctional ischaemic myocardium: implications of regional flow-function relations.
    Piérard LA
    Acta Cardiol; 2001 Aug; 56(4):207-10. PubMed ID: 11573824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.